Combination therapy: Future directions of immunotherapy in small cell lung cancer

Small cell lung cancer (SCLC), an aggressive and devastating malignancy, is characterized by rapid growth and early metastasis. Although most patients respond to first-line chemotherapy, the majority of patients rapidly relapse and have a relatively poor prognosis. Fortunately, immunotherapy, mainly...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wei, Chen, Jia-Jia, Xing, Rui, Zeng, Yue-Can
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Review article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567053/
https://www.ncbi.nlm.nih.gov/pubmed/33065386
http://dx.doi.org/10.1016/j.tranon.2020.100889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567053/
https://www.ncbi.nlm.nih.gov/pubmed/33065386
http://dx.doi.org/10.1016/j.tranon.2020.100889

Ejemplares similares